STATAstraZeneca lung cancer immunotherapy trial failure sends shares plungingSTAThighly anticipated clinical trial combining two immunotherapy drugs failed to delay tumor growth in patients with newly diagnosed lung cancer, sending AstraZeneca sharply … Continue reading
City A.M. |
AstraZeneca Shares Plunge 16 Percent as Lung Cancer Study Fails
New York Times LONDON — AstraZeneca’s combination of two injectable immunotherapy drugs failed to help patients as hoped in a closely watched advanced lung cancer trial, sending its shares plunging on Thursday. The so-called MYSTIC study was the most anticipated … Shares in pharma giant AstraZeneca plunge more than 15% after lung cancer drug trial setbackBusiness Insider AstraZeneca Shares Crash the Most on Record After Key Cancer Drug FailsTheStreet.com Astra plunges as vital cancer drug fails trialEvening Standard Financial Times all 35 news articles » |
|
Immunotherapy setback for AstraZeneca
Seeking Alpha AstraZeneca (NYSE:AZN) -15% premarket after the trial of its new lung cancer drug failed to reach its “endpoints” for progression free survival – the length for which people go without their condition worsening. The study, known as Mystic, featured an … |
|
Immunotherapy setback for AstraZeneca
Seeking Alpha AstraZeneca (NYSE:AZN) -15% premarket after the trial of its new lung cancer drug failed to reach its “endpoints” for progression free survival – the length for which people go without their condition worsening. The study, known as Mystic, featured an … |
WhaTech |
Stem cell-based method selectively targets cancerous tissue while preventing toxic side effects
News-Medical.net A stem cell-based method created by University of California, Irvine scientists can selectively target and kill cancerous tissue while preventing some of the toxic side effects of chemotherapy by treating the disease in a more localized way. Weian Zhao … Tumor Tissue Stiffness Exploited for MSC or Potentially CAR T-Cell TherapeuticsGenetic Engineering & Biotechnology News Mesenchymal stem cells market grows with increasing clinical application for the treatment of chronic disease …WhaTech Circulating Tumor Cells and Cancer Stem Cells Market Foreseen to Grow Exponentially Over 2017 – 2025MilTech |